Cardiovascular Diseases Research in Utah
Cardiovascular Diseases Research (93.837) awarded $140 million to recipients in Utah in 141 grants from fiscal 2021 to 2025, 0.9% of the program's national total. University of Utah received the most, $129 million.
- Awarded in Utah$140 million
- Awards141
- Share of the program0.9%
- Rank among states24th of 51
- National total$15 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 57 | $21.9 million |
| FY 2022 | 66 | $25.3 million |
| FY 2023 | 77 | $30.4 million |
| FY 2024 | 72 | $28.9 million |
| FY 2025 | 77 | $33.8 million |
Recipients in Utah
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| University of Utah | Colleges and universities | 131 | $129 million |
| Ihc Health Services Inc | Nonprofits | 4 | $6.8 million |
| N8 Medical Inc | Small businesses | 1 | $2.0 million |
| Brigham Young University | Colleges and universities | 2 | $996,764 |
| Utah State University | Colleges and universities | 1 | $414,664 |
| Cathpro Technologies, LLC. | Small businesses | 1 | $310,170 |
| Bioparin, LLC | Small businesses | 1 | $306,656 |
Open opportunities under this program
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
- Emerging Global Leader Award (K43 Independent Clinical Trial Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
- NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 82 on the program page
Questions people ask
How much Cardiovascular Diseases Research money goes to Utah?
$140 million from fiscal 2021 to 2025, across 141 awards. Utah ranks 24th of 51 states and territories for this program.
Who receives Cardiovascular Diseases Research money in Utah?
The largest recipient is University of Utah, with $129 million in 131 awards. Next are Ihc Health Services Inc and N8 Medical Inc.
Can organizations in Utah apply now?
Yes, 82 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cardiovascular Diseases Research in other states
Other large programs in Utah
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Child Care and Development Block Grant
- Special Education Grants to States
- Airport Improvement Program, Infrastructure Investment and Jobs Act Programs, and COVID-19 Airports Programs
- Children's Health Insurance Program
- Head Start
- Federal Transit Formula Grants